Hawkes Pharmacy 2007 Limited 06263665 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is that of a retail pharmacy. Digita Accounts Production Advanced 6.30.9574.0 true true 06263665 2025-04-01 2026-03-31 06263665 2026-03-31 06263665 core:AcceleratedTaxDepreciationDeferredTax 2026-03-31 06263665 core:FinancialAssetsCostLessImpairment 2026-03-31 06263665 core:CurrentFinancialInstruments 2026-03-31 06263665 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 06263665 core:Goodwill 2026-03-31 06263665 core:BetweenTwoFiveYears 2026-03-31 06263665 core:MoreThanFiveYears 2026-03-31 06263665 core:WithinOneYear 2026-03-31 06263665 core:FurnitureFittingsToolsEquipment 2026-03-31 06263665 core:LandBuildings 2026-03-31 06263665 bus:SmallEntities 2025-04-01 2026-03-31 06263665 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 06263665 bus:FilletedAccounts 2025-04-01 2026-03-31 06263665 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 06263665 bus:RegisteredOffice 2025-04-01 2026-03-31 06263665 bus:Director1 2025-04-01 2026-03-31 06263665 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 06263665 bus:Agent1 2025-04-01 2026-03-31 06263665 core:Goodwill 2025-04-01 2026-03-31 06263665 core:ComputerEquipment 2025-04-01 2026-03-31 06263665 core:FurnitureFittings 2025-04-01 2026-03-31 06263665 core:FurnitureFittingsToolsEquipment 2025-04-01 2026-03-31 06263665 core:LandBuildings 2025-04-01 2026-03-31 06263665 countries:EnglandWales 2025-04-01 2026-03-31 06263665 2025-03-31 06263665 core:Goodwill 2025-03-31 06263665 core:FurnitureFittingsToolsEquipment 2025-03-31 06263665 core:LandBuildings 2025-03-31 06263665 2024-04-01 2025-03-31 06263665 2025-03-31 06263665 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 06263665 core:FinancialAssetsCostLessImpairment 2025-03-31 06263665 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 06263665 core:Goodwill 2025-03-31 06263665 core:BetweenTwoFiveYears 2025-03-31 06263665 core:MoreThanFiveYears 2025-03-31 06263665 core:WithinOneYear 2025-03-31 06263665 core:FurnitureFittingsToolsEquipment 2025-03-31 06263665 core:LandBuildings 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 06263665

Prepared for the registrar
Hawkes Pharmacy 2007 Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 31 March 2026

Hawkes Pharmacy 2007 Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Financial Statements | 3 to 8

Hawkes Pharmacy 2007 Limited

Company Information

Director | H Hawkes

Registered office | 52 Windermere Road Cheltenham Gloucestershire GL51 3PH

Accountants | Hazlewoods LLP Staverton Court Staverton Cheltenham GL51 0UX

Hawkes Pharmacy 2007 Limited

(Registration number: 06263665)
Balance Sheet as at 31 March 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Intangible assets | 4 | 439,152 | 487,946
Tangible assets | 5 | 25,465 | 7,022
Other financial assets | 6 | 450 | 450
|  | 465,067 | 495,418
Current assets |  |  |
Stocks |  | 36,706 | 38,902
Debtors | 7 | 206,486 | 197,002
Cash at bank and in hand |  | 6,551 | 108,598
|  | 249,743 | 344,502
Creditors: Amounts falling due within one year | 8 | (132,679) | (170,930)
Net current assets |  | 117,064 | 173,572
Total assets less current liabilities |  | 582,131 | 668,990
Deferred tax liabilities | 9 | (4,838) | (1,756)
Net assets |  | 577,293 | 667,234
Capital and reserves |  |  |
Called up share capital |  | 1,000 | 1,000
Retained earnings |  | 576,293 | 666,234
Shareholders' funds |  | 577,293 | 667,234

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 20 July 2026

H Hawkes
Director

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2026

| 1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
52 Windermere Road
Cheltenham
Gloucestershire
GL51 3PH

| 2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2026

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Furniture, fittings and equipment | 15% reducing balance basis
Computer equipment | 33.3% reducing balance basis

Goodwill

Goodwill is amortised over its useful life, estimated by the directors to be 20 years.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2026

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2026

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.
A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

| 3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

| 2026 No. | 2025 No.
Average number of employees | 13 | 13

| 4 | Intangible assets

| Goodwill £ | Total £
Cost
At 1 April 2025 | 975,886 | 975,886
At 31 March 2026 | 975,886 | 975,886
Amortisation
At 1 April 2025 | 487,940 | 487,940
Amortisation charge | 48,794 | 48,794
At 31 March 2026 | 536,734 | 536,734
Carrying amount
At 31 March 2026 | 439,152 | 439,152
At 31 March 2025 | 487,946 | 487,946

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2026

| 5 | Tangible assets

| Leasehold Improvements £ | Furniture, fittings and equipment £ | Total £
Cost
At 1 April 2025 | - | 67,889 | 67,889
Additions | 12,333 | 9,150 | 21,483
At 31 March 2026 | 12,333 | 77,039 | 89,372
Depreciation
At 1 April 2025 | - | 60,867 | 60,867
Charge for the year | 257 | 2,783 | 3,040
At 31 March 2026 | 257 | 63,650 | 63,907
Carrying amount
At 31 March 2026 | 12,076 | 13,389 | 25,465
At 31 March 2025 | - | 7,022 | 7,022

| 6 | Other financial assets (current and non-current)

| Financial assets at cost less impairment £ | Total £
Non-current financial assets
Cost or valuation
At 1 April 2025 | 450 | 450
At 31 March 2026 | 450 | 450
Carrying amount
At 31 March 2026 | 450 | 450
At 31 March 2025 | 450 | 450

| 7 | Debtors

| 2026 £ | 2025 £
Trade debtors | 181,761 | 160,659
Prepayments | 1,384 | 2,605
Other debtors | 2,353 | 15,441
VAT repayable | 20,988 | 18,297
| 206,486 | 197,002

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2026

| 8 | Creditors

| 2026 £ | 2025 £
Due within one year |  |
Trade creditors | 116,709 | 112,330
Taxation and social security | 5,086 | 49,375
Accruals and deferred income | 10,884 | 9,225
| 132,679 | 170,930

| 9 | Deferred tax

Deferred tax assets and liabilities

2026 | Liability £
Capital allowances in excess of depreciation | 4,838
| 4,838

2025 | Liability £
Capital allowances in excess of depreciation | 1,756
| 1,756

| 10 | Financial commitments

Operating leases

The total of future minimum lease payments is as follows:

| 2026 £ | 2025 £
Not later than one year | 6,635 | 6,635
Later than one year and not later than five years | 26,540 | 26,540
Later than five years | 33,175 | 39,810
| 66,350 | 72,985

The amount of non-cancellable operating lease payments recognised as an expense during the year was £4,796 (2025 - £5,861).